IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RONCA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.397
EU - Europa 6.172
AS - Asia 5.033
SA - Sud America 819
AF - Africa 133
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 11
Totale 22.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.159
PL - Polonia 2.556
SG - Singapore 1.669
CN - Cina 1.579
IT - Italia 801
DE - Germania 698
UA - Ucraina 662
BR - Brasile 648
HK - Hong Kong 522
VN - Vietnam 401
FI - Finlandia 336
GB - Regno Unito 255
FR - Francia 216
BD - Bangladesh 175
RU - Federazione Russa 171
TR - Turchia 166
IN - India 164
CA - Canada 142
IE - Irlanda 139
NL - Olanda 63
AR - Argentina 62
ID - Indonesia 59
SE - Svezia 55
ZA - Sudafrica 52
JP - Giappone 49
MX - Messico 46
ES - Italia 42
CZ - Repubblica Ceca 39
AU - Australia 36
BE - Belgio 34
IQ - Iraq 32
PK - Pakistan 24
CL - Cile 23
EC - Ecuador 23
AT - Austria 22
IR - Iran 19
CO - Colombia 18
TW - Taiwan 18
SA - Arabia Saudita 17
MA - Marocco 16
NG - Nigeria 14
VE - Venezuela 14
AZ - Azerbaigian 13
PH - Filippine 13
CH - Svizzera 12
JM - Giamaica 12
JO - Giordania 12
KR - Corea 11
LT - Lituania 11
PE - Perù 11
PY - Paraguay 11
TH - Thailandia 11
KE - Kenya 10
MY - Malesia 10
NO - Norvegia 10
TN - Tunisia 10
UZ - Uzbekistan 10
BG - Bulgaria 9
CR - Costa Rica 9
EU - Europa 9
IL - Israele 9
AE - Emirati Arabi Uniti 8
LK - Sri Lanka 8
EG - Egitto 7
ET - Etiopia 7
MU - Mauritius 6
UY - Uruguay 6
GR - Grecia 5
HR - Croazia 5
GE - Georgia 4
KZ - Kazakistan 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AL - Albania 3
AW - Aruba 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GD - Grenada 3
HN - Honduras 3
HU - Ungheria 3
KH - Cambogia 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZM - Zambia 2
Totale 22.579
Salva come PNG Salva come JPEG
Città #
Warsaw 2.549
Ashburn 1.099
Fairfield 1.067
Singapore 959
Woodbridge 670
Hong Kong 513
Jacksonville 496
Houston 490
San Jose 450
Seattle 413
Cambridge 412
Ann Arbor 349
Chandler 347
Beijing 337
Wilmington 334
The Dalles 313
Brescia 303
New York 253
Los Angeles 242
Princeton 237
Helsinki 223
Nanjing 152
Munich 149
Dublin 135
Lauterbourg 131
Istanbul 129
Council Bluffs 128
Dearborn 123
Dallas 116
Ho Chi Minh City 115
San Francisco 93
Dong Ket 90
Chicago 84
Buffalo 80
Shanghai 80
Milan 78
Orem 75
São Paulo 70
Des Moines 67
Hanoi 65
Santa Clara 63
Moscow 58
Redondo Beach 54
Changsha 48
Jakarta 48
Nanchang 48
Phoenix 48
Montreal 47
Shenyang 46
San Diego 45
Brooklyn 44
London 42
Hebei 40
Tokyo 40
Toronto 39
Hangzhou 38
Atlanta 36
Jinan 36
Denver 35
Chennai 33
Frankfurt am Main 33
Tianjin 33
Brussels 32
Lancaster 32
Rome 32
Stockholm 32
Turku 30
Brno 27
Amsterdam 26
Johannesburg 26
Guangzhou 23
Lappeenranta 22
Boardman 21
Boston 20
Nuremberg 20
Kunming 19
Rio de Janeiro 18
Washington 18
Belo Horizonte 17
Manchester 17
Melbourne 17
Mumbai 17
Ningbo 16
Taizhou 16
Haiphong 15
Verona 15
Falkenstein 14
Poplar 14
Porto Alegre 14
San Mateo 14
Abuja 13
Baku 13
Charlotte 13
Jiaxing 13
Zhengzhou 13
Amman 12
Baghdad 12
Dhaka 12
Florence 12
Haikou 12
Totale 15.679
Salva come PNG Salva come JPEG
Nome #
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 585
Tumor angiogenesis revisited: Regulators and clinical implications 432
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 386
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 356
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 343
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 316
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 306
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 302
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 290
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 288
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 287
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 283
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 272
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 271
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 267
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 262
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 259
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 255
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 250
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 226
Stromal delivery of long Pentraxin-3 impairsFGF7FGFR-dependent tumor growth and metastasis 225
Long pentraxin-3 follows and modulates bladder cancer progression 223
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 222
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 214
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 213
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 206
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 205
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 202
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 202
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 202
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 197
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 195
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 194
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 191
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 190
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 189
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 189
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 187
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 187
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 186
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 185
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 185
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 184
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 182
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 182
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 177
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 177
Beta-Galactosylceramidase deficiency: neurovascular implications 176
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 174
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents 174
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 172
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 171
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 169
Circulating microRNAs and Their Role in Multiple Myeloma 169
Long pentraxin 3: A novel multifaceted player in cancer 167
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 163
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 163
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 163
Future applications of FGF/FGFR inhibitors in cancer 154
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 152
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 150
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies 149
Ten Years of CRISPRing Cancers In Vitro 146
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 146
Vascular disrupting activity of combretastatin analogues 146
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 145
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 144
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 144
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 143
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 143
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 142
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 140
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 139
Heparin derivatives as angiogenesis inhibitors 138
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 135
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 134
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 131
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 130
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 130
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 125
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 120
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 120
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 120
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation 119
Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells 118
Collagen/PCL electrospun fibers loaded with polyphenols: Curcumin and resveratrol comparison 117
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 117
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 117
HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies 117
Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors 114
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 114
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 114
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 112
Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: Ex Novo Synthesis, Crystallography, In Silico Studies, and Anti-Melanoma Cell Line Activity 111
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 111
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 111
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 110
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells 108
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 108
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 107
Totale 18.779
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.124 88 199 47 27 19 53 73 74 45 116 100 283
2022/20231.027 175 32 57 56 99 241 6 90 145 4 64 58
2023/20241.263 76 30 136 54 48 207 52 73 260 63 56 208
2024/20252.929 34 40 43 445 240 268 250 160 373 210 488 378
2025/20266.866 607 706 415 836 750 482 1.046 312 421 623 329 339
2026/2027340 340 0 0 0 0 0 0 0 0 0 0 0
Totale 22.979